Dexmedetomidine Injection, Solution, Concentrate
Product Images NDC 67457-251

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 67457-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexmedetomidine Structural Formula (92cb0471 C991 48df 9cc2 C8bd54c5c0a7 01)

Dexmedetomidine Structural Formula (92cb0471 C991 48df 9cc2 C8bd54c5c0a7 01)
Chemical structure of dexmedetomidine hydrochloride, showing its molecular configuration with labeled carbon, hydrogen, nitrogen atoms, and hydrochloride group.*
FDA Label Image

Dexmedetomidine Injection, Usp 200 Mcg/2 mL Carton Label (Image 01)

Dexmedetomidine Injection, Usp 200 Mcg/2 mL Carton Label (Image 01)
Packaging label for Dexmedetomidine Injection, USP, 200 mcg/2 mL (100 mcg/mL) concentrate for intravenous infusion. The label indicates the product is for injection only and must be diluted. The package contains 25 single-dose 2 mL vials. Manufactured and distributed by Mylan Institutional LLC. Includes NDC 67457-251-02 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.